Question #104
Reading: Reading 22 Market-Based Valuation - Price and Enterprise Value Multiples
PDF File: Reading 22 Market-Based Valuation - Price and Enterprise Value Multiples.pdf
Page: 36
Status: Unattempted
Part of Context Group: Q104-107
First in Group
Shared Context
Question
Barnes is contemplating the use of a price/earnings ratio to value a start-up medical technology firm. Which of the following is the most compelling reason not to use the P/E ratio?
Answer Choices:
A. P/E ratios for medical-technology firms with different specialties are not comparable
B. The company is likely to be unprofitable
C. Earnings per share are not a good determinant of investment value for medical- technology companies
Explanation
Earnings are the chief determinant of value for most companies, including med-tech. P/E is
the most common valuation method and the best known by lay investors. Comparability of
P/E ratios across industries is always problematic, but not as much so for within the med-
tech industry. A start-up company is very likely to have negative earnings, which renders
the P/E ratio useless.